COVID-19 and HIV

Roy M. Gulick, MD, MPH
Rochelle Belfer Professor in Medicine
Chief, Division of Infectious Diseases
Weill Cornell Medicine, New York, NY



VIDEOTop of page

About the Presenter:Top of page

Roy Gulick’s research interests include designing, conducting, and analyzing clinical trials to refine antiretroviral therapy strategies for HIV treatment and prevention and assess antiretroviral agents with new mechanisms of action. He is PI of the Cornell-New Jersey HIV Clinical Trials Unit of the ACTG and the HPTN, sponsored by the NIH. He also serves as the Co-Chair of the DHHS Panel on Clinical Practices for Treatment of HIV Infection, Chair of the NIH Office of AIDS Research Advisory Committee, and previously served as Chairman of the Antiviral Drugs Advisory Committee of the FDA.

Learning Objectives: Top of page

At the completion of this educational session, learners will:

  • To discuss the clinical features of COVID-19 in the setting of HIV infection
  • To identify current and prospective COVID-19 treatments for people living with HIV
  • To review current guidelines for people living with HIV in the time of COVID-19

Financial Support:Top of page

This PRN CME activity is funded in part by unrestricted educational grants from: Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare

You must be logged in to post a comment. Login | Register